Skip to main content

MDL Judge Dismisses 4 Paraquat Cases, Excludes Expert

MDL Judge Dismisses 4 Paraquat Cases, Excludes Expert

MDL Judge Dismisses 4 Paraquat Cases, Excludes Expert

Introduction

The U.S. District Judge overseeing the Paraquat Parkinson’s disease lawsuits has barred a key expert witness from testifying at trial, leading to the dismissal of four bellwether cases lacking the necessary support to proceed.

These cases are part of a larger litigation against Syngenta and Chevron, encompassing over 5,000 lawsuits alleging Paraquat exposure causes Parkinson’s disease. Plaintiffs contend manufacturers failed to sufficiently warn about Paraquat risks during handling.

Expert witnesses were proposed to validate the Paraquat-Parkinson’s link, citing research indicating Paraquat's potential to induce the disease. However, manufacturers refute these assertions, maintaining the herbicide's safety.

All federal Paraquat lawsuits are centralized in the Southern District of Illinois as multidistrict litigation. Bellwether trials, intended to predict jury responses, are crucial components of this process.

During the Paraquat “Daubert” hearings, the Judge evaluated the proposed expert testimony's reliability. Defendants sought the exclusion of an epidemiologist and statistician from Cornell University, pivotal in establishing causation in four bellwether cases.

In a subsequent memorandum and order, the Judge sided with the defendants, excluding the expert testimony due to insufficient evidence linking Paraquat to Parkinson’s disease. As this expert was key to plaintiffs’ causation arguments, all four bellwether trials were dismissed.

This ruling underscores the litigation’s complexity and the challenges associated with proving causation in Paraquat-related Parkinson’s disease cases. While these developments represent setbacks for plaintiffs, the legal process continues, with further proceedings expected in the multidistrict litigation.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Lawyers to Meet Nov. 5 for Talcum Powder Trial Prep

Categories: Talcum

As the first federal talcum powder bellwether trial approaches, both plaintiffs and defendants have finalized their legal teams and are preparing for a key pretrial conference scheduled for early November.

The upcoming proceedings mark a…

2025 Update: What to Know About PPI Lawsuit Settlements & Payout Dates

Categories: Settlements

Last updated on Oct 27, 2025.

The mass tort litigation involving proton pump inhibitor (PPI) drugs — such as Nexium, Prilosec, Prevacid and Protonix — is entering a pivotal phase in

New Front Emerges in Fight Against Synthetic Opioids

Categories: Opioids

The U.S. opioid crisis has already claimed hundreds of thousands of lives, with fentanyl standing out as one of the deadliest substances. Now the leading cause of death among Americans aged 18 to 44, fentanyl has become synonymous with overdose…

⏳ Save 20+ Hours Weekly — We’ll Organize Your Medical Records FREE!                     
💼 Delivered in 7 Days. No AI. No Contracts.
Handled by Real Attorneys & Doctors — 100% HIPAA-Compliant.

Only 1 Free Slot remain — Offer Ends Soon!